Cancer Stem Cells-Therapeutic Boon!

Journal of Cancer Science and Therapy

Volumn 3, Issue 8, 2011, Pages 197-200

  Shrihari, T G ^a  

^a Krishnadevaraya Dental College and Hospital   (India)

Author keywords

Aldehyde dehydrogenase (ALDHs); ATP binding cassette (ABC); Melanoma chondroitin sulphate proteoglycans(MCSP); Microtubule associated protein (MAC); Tumor stem cells

Indexed keywords

ALDEHYDE DEHYDROGENASE; CARMUSTINE; CD133 ANTIGEN; CD24 ANTIGEN; CD44V ANTIGEN; CYCLOPHOSPHAMIDE; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MAMMALIAN TARGET OF RAPAMYCIN; MICROTUBULE ASSOCIATED PROTEIN 4; PROTEIN BCL 2; PROTEIN BCL XL; TEMOZOLOMIDE;

ALKYLATION; APOPTOSIS; ARTICLE; BREAST TUMOR; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER RESISTANCE; CANCER STEM CELL; CARCINOGENESIS; CELL ADHESION; CELL HETEROGENEITY; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL RENEWAL; CELL SURFACE; CELL SURVIVAL; CLINICAL RESEARCH; COLONY FORMING CELL; DNA DAMAGE; DNA REPAIR; DOWN REGULATION; DRUG RESISTANCE; ENZYME ACTIVITY; GENE EXPRESSION; IN VITRO STUDY; IN VIVO STUDY; LIFESPAN; OSTEOSARCOMA; OXIDATION; SIGNAL TRANSDUCTION; STEM CELL; TREATMENT RESPONSE; TUMOR GROWTH; UPREGULATION;

EID: 84857083387     PISSN: None     EISSN: 19485956     Source Type: Journal    
DOI: 10.4172/1948-5956.1000088     Document Type: Article

References (44)

1. Spangrude GJ, Heimfeld S, Weissman IL (1988) Purification and characterization of mouse hematopoietic stem cells. Science 241: 58-62.
2. Morrison SJ, Weissman IL (1994) The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. Immunity 1: 661-673.
3. Lagasse E, Connors H, Al-Dhalimy M, Reitsma M, Dohse M, et al. (2000) Purified hematopoietic stem cells can differentiate to hepatocytes in vivo. Nat Med 6: 1229-1234.
4. Krause DS, Theise ND, Collector MI, Henegariu O, Hwang S, et al. (2001) Multi-organ, multi-lineage engraftment by a single bone marrow derived stem cell. Cell 105: 369-377.
5. Shoemaker RH, Wolpert-DeFilippes MK, Kern DH, Lieber MM, Makuch RW, et al. (1985) Application of a human tumor colony-forming assay to new drug screening. Cancer Res 45: 2145-2153.
6. Yu SC, Ping YF, Yi L, Zhou ZH, Chen JH, et al. (2008) Isolation and characterization of cancer stem cells from a human glioblastoma cell line U87. Cancer Lett 265: 124-134.
7. Wright MH, Calcagno AM, Salcido CD, Carlson MD, Ambudkar SV, et al.(2008) Brca1 breast tumors contain distinct CD44 + / CD24) andCD133 + cells with cancer stem cell characteristics. Breast Cancer Res 10: R10.
8. Boman BM, Wicha MS (2008) Cancer stem cells: a step toward the cure. J Clin Oncol 26: 2795-2799.
9. Vermeulen L, Todaro M, de Sousa Mello F, Sprick MR, Kemper K, et al. (2008) Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc Natl Acad Sci U S A 105: 13427-13432.
10. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, et al. (2003) Identification of a cancer stem cell in human brain tumors. Cancer Res 63: 5821-5828.
11. Bidlingmaier S, Zhu X, Liu B (2008) The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells. J Mol Med 86: 1025-1032.
12. Croker AK, Goodale D, Chu J, Postenka C, Hedley BD, et al. (2008) High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability. J Cell Mol Med 13: 2236-52.
13. Ucar D, Cogle CR, Zucali JR, Ostmark B, Scott EW, et al. (2009) Aldehyde dehydrogenase activity as a functional marker for lung cancer. Chem Biol Interact 178: 48-55.
14. Birnie R, Bryce SD, Roome C, Dussupt V, Droop A, et al. (2008) Gene expression profiling of human prostate cancer stem cells reveals a proinflammatory phenotype and the importance of extracellular matrix interactions. Genome Biol 9: R83.
15. Li X, Lewis MT, Huang J, Gutierrez C, Osborne CK, et al. (2008) Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J Natl Cancer Inst 100: 672-679.
16. Gillette J, Nielsen-Preiss S (2009) Cancer stem cells: seeds of growth in osteosarcoma. Cancer Biol Ther 8: 553-554.
17. Kvinlaug BT, Huntly BJP (2007) Targeting cancer stem cells. Expert Opin Ther Targets 11: 915-927.
18. Raguz S, Yague E (2008) Resistance to chemotherapy: new treatments and novel insights into an old problem. Br J Cancer 99: 387-391.
19. Sneddon JB, Werb Z (2007) Location, location, location: the cancer stem cell niche. Cell Stem Cell 1: 607-611.
20. Gordan JD, Thompson CB, Simon MC (2007) HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation. Cancer Cell 12: 108-113.
21. Keith B, Simon MC (2007) Hypoxia-inducible factors, stem cells, and cancer. Cell 129: 465-472.
22. Jensen KB, Jones J, Watt FM (2008) A stem cell gene expression profile of human squamous cell carcinomas. Cancer Lett 272: 23-31.
23. Jensen KB, Watt FM (2006) Single-cell expression profiling of human epidermal stem and transit-amplifying cells: Lrig1 is a regulator of stem cell quiescence. Proc Natl Acad Sci USA 103: 11958-11963.
24. Gur G, Rubin C, Katz M, Amit I, Citri A, et al. (2004) LRIG1 restricts growth factor signalling by enhancing receptor ubiquitylation and degradation. EMBO J 23: 3270-3281.
25. Laederich MB, Funes-Duran M, Yen L, Ingalla E, Wu X, et al. (2004) The leucine-rich repeat protein LRIG1 is a negative regulator of ErbB family receptor tyrosine kinases. J Biol Chem 279: 47050-47056.
26. Andersen SS (2000) Spindle assembly and the art of regulating microtubule dynamics by MAPs and Stathmin / Op18. Trends Cell Biol 10: 261-267.
27. Eisenmann KM, McCarthy JB, Simpson MA, Keely PJ, Guan J, et al. (1999) Melanoma chondroitin sulphate proteoglycan regulates cell spreading through Cdc42, Ack-1 and p130cas. Nat Cell Biol 1: 507-513.
28. Majumdar M, Vuori K, Stallcup WB (2003) Engagement of the NG2 proteoglycan triggers cell spreading via rac and p130cas. Cell Signal 15: 79-84.
29. Iwasaki H, Suda T (2009) Cancer stem cells and their niche. Cancer Sci 100: 1166-1172.
30. Johannessen TC, Bjerkvig R, Tysnes BB (2008) DNA repair and cancer stemlike cells - potential partners in glioma drug resistance? Cancer Treat Rev 34: 558-567.
31. Liu G, Yuan X, Zeng Z, Tunici P, Ng H, et al. (2006) Analysis of gene expression and chemo resistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer 5: 67.
32. Jin F, Zhao L, Zhao HY, Guo SG, Feng J, et al. (2008) Comparison between cells and cancer stem-like cells isolated from glioblastoma and astrocytoma on expression of antiapoptotic and multidrug resistance-associated protein genes. Neuroscience 154: 541-550.
33. Dean M (2009) ABC transporters, drug resistance, and cancer stem cells. J Mammary Gland Biol and Neoplasia 14: 3-9.
34. Schatton T, Murphy GF, Frank NY, Yamaura K, Waaga-Gasser AM, et al. (2008) Identification of cells initiating human melanomas. Nature 451: 345-349.
35. Tirino V, Desiderio V, d'Aquino R, De Francesco F, Pirozzi G, et al. (2008) Detection and characterization of CD133 + cancer stem cells in human solid tumours. PLoS ONE 3: e3469.
36. Frank NY, Margaryan A, Huang Y, Schatton T, Waaga-Gasser AM, et al. (2005) ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma. Cancer Res 65: 4320-4333.
37. Harley CB (2008) Telomerase and cancer therapeutics. Nat Rev Cancer 8: 167-179.
38. Shay JW, Keith WN (2008) Targeting telomerase for cancer therapeutics. Br J Cancer 98: 677-683.
39. Bleau AM, Hambardzumyan D, Ozawa T, Fomchenko EI, Huse JT, et al. (2009) PTEN / PI3K / Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells. Cell Stem Cell 4: 226-235.
40. Peacock CD, Wang Q, Gesell GS, Corcoran-Schwartz IM, Jones E, et al. (2007) Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma. Proc Natl Acad Sci 104: 4048-4053.
41. Gupta PB, Onder TT, Jiang G, Tao K, Kuperwasser C, et al. (2009) Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 138: 645-659.
42. Saini V, Martyshkin DV, Mirov SB, Perez A, Perkins G, et al. (2008) An adenoviral platform for selective self-assembly and targeted delivery of nanoparticles. Small 4: 262-269.
43. Saini V, Roth JC, Pereboeva L, Everts M (2007) Importance of viruses and cells in cancer gene therapy. Adv Gene Mol Cell Ther 1: 30-43.
44. Saini V, Zharov VP, Brazel CS, Nikles DE, Johnson DT, et al. (2006) Combination of viral biology and nanotechnology: new applications in nanomedicine. Nanomedicine 2: 200-206.